Major restructuring and executive team changes over the past year have positioned the organization to better navigate a challenging macro environment and respond effectively to market shifts.
Commercial restructuring included reassignment of territories and roles, creating specialized teams for CapEx instruments, biopharma, and academia, improving agility and visibility across business segments.
The new structure has enabled more effective funnel management, opportunity development, and account opening, despite macroeconomic headwinds impacting high CapEx and biopharma demand.
The organization is focused on controlling internal factors and preparing to capitalize on opportunities as the external environment stabilizes.
Leadership expresses confidence in the team's ability to execute and drive business forward, even amid ongoing uncertainty.
The external environment remains uncertain, with ongoing issues in funding dispersal, multi-year funding, and indirect cost caps affecting universities.
Customer sentiment has improved compared to earlier in the year, though unpredictability persists in both academic and biopharma sectors.
There is cautious optimism for improved funding and activity levels heading into the next year and beyond, especially as NIH and other funding sources stabilize.
Ongoing price reductions and new product configurations in single cell consumables have driven consistent volume growth, leveraging market elasticity.
The recent launch of the Flex assay on Chromium offers lower per-sample pricing at higher volumes, expected to further boost adoption and volume.
The business is approaching a more normalized balance between pricing and volume, with significant market capacity remaining for single cell adoption.
Competitive positioning has improved, with strong advantages in data quality, workflow, and customer satisfaction; price is no longer a major vulnerability.
The company remains sequencer-agnostic, with partnerships expanding to new platforms like Ultima and Roche, enhancing customer value.
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Search for any keyword across all transcripts simultaneously.
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
The easiest way to stay updated during earnings season.
All events from public companies. Live and recorded.
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage